IME Programs


The Alnylam grants office supports independent medical education activities provided to healthcare professionals (HCPs) to help close the professional practice gaps of learners and address their unmet educational needs. Activities should strive to ultimately improve patient care and must be compliant with all applicable legal and regulatory guidelines. Educational grants are considered financial awards for clinical, scientific, and disease state educational programs that provide meaningful education to healthcare professionals and researchers in areas of relevance to Alnylam, without tangible benefit to Alnylam in return.


As part of our ongoing commitment to putting patients first, Alnylam will accept grant requests for bona fide educational purposes from the following:

  • Educational providers that are accredited to provide continuing education (ie, CME, CE) by a national accrediting body, such as the Accreditation Council for Continuing Medical Education (ACCME), American Nurses Credentialing Center (ANCC), Accreditation Council for Pharmacy Education (ACPE), or other such accreditor. Alnylam will also support Independent Medical Education (IME) that is not designated for credit.

    Educational providers can be any of the following types:

    Continuing education offices of academic medical centers, medical universities, hospitals, or community health centers

    Professional medical societies/associations

    Managed care organizations

    Medical education partner companies/providers


Submit a Request ›

Medical Education Areas of Interest

Throughout the year, Alnylam will post Request for Educational Grant Proposals (REGP) to inform organizations and qualified medical education providers that we are interested in receiving requests for independent medical education activities pertinent to Alnylam’s areas of interest and aligned to specifications outlined in our REGPs.

The following are the available Request for Grant Proposals:

Identifying and evaluating patients at high risk of monogenic kidney stone disorders including Primary Hyperoxaluria Type 1

Current budget availability for each theraputic area


Budget Available
Limited Funding Available
Budget Unavailable
Transthyretin-mediated amyloidosis (ATTR amyloidosis)


  Increased awareness of TTR amyloidosis, including distinction between hereditary and wild-type
  Improved clinical knowledge of the patient’s journey, disease burden, and identification of core symptoms
  Increased awareness of the multisystemic nature of the disease and the implications for multidisciplinary diagnosis and management
  Increased understanding of measurement and detection of disease progression
  Improved knowledge of genetic testing & counseling and implications for broader family


Acute hepatic porphyria


  Increased awareness of acute hepatic porphyria, including differential diagnosis of unexplained abdominal pain and neurological symptoms
  Improved knowledge of ordering and evaluating tests for extreme abdominal pain
  Increased competence of management of porphyria, including burden of disease and patient experience


Primary hyperoxaluria type 1 (PH1)


  Increased awareness & improved clinical knowledge of PH1, including burden of disease
  Increased competence of kidney stone management guideline adherence
  Increased knowledge of monogenic stones & genetic testing
Supporting Documents


Download the Medical Education Grants at a Glance (PDF)

Download the Educational Grant Budget Template (Excel)


Receive news and updates on the work at Alnylam that affects you most.